Text message reminders to help women take breast cancer pills
Part of Cancer, Skin clinical trials.
This study tests whether text message reminders help women with early-stage, hormone-sensitive breast cancer remember to take their daily cancer-prevention medication. The goal is to see if reminders improve how consistently women take their pills, which can help prevent cancer from coming back.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman, age 18 or older
- You have been diagnosed with ER-positive breast cancer (a type of breast cancer that grows with estrogen)
- Your cancer was found only in the breast and nearby lymph nodes—not spread elsewhere in your body
- You started taking daily hormone-blocking medication (AET) within the last 6–36 months
- You own a cellphone that can receive text messages
- You are currently receiving your cancer treatment at Butaro clinic or one of its satellite clinics in Rwanda
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether daily text message reminders and a small tracking device (WisePill) can help people who recently started HIV medication stay on track. It's designed for people who began treatment in the past 2 months and are willing to receive texts and use the device.
This trial tests an intervention to help improve how equitably people take their prescribed breast cancer hormone therapy and heart-related prevention medicines. It may help if you have had trouble taking these medications as directed.
This study tests a program to help people with metastatic breast cancer take their oral medications as prescribed. It uses a smartphone app to track and support medication adherence, which may improve treatment outcomes.
This study tests a pharmacy-based program (called PACHA) designed to help women remember and stick with hormone (endocrine) treatment after breast cancer. It may help by improving support and follow-through during the first months after starting the pills.
This study tests a program to help people with metastatic breast cancer take their endocrine therapy, CDK4/6 inhibitors, and heart-related medications as prescribed. If you sometimes miss doses of these medicines, you may be able to join.
This trial tests a digital tool (a smartphone app) to help women and men with early breast cancer manage side effects from hormone therapy. The goal is to improve quality of life during treatment.
Hear when a new Medication Adherence trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.